Study Contributors

COVIDRIVE’s Study Contributors network consists of 31 study sites from 14 different countries in the European continent: Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom. Our network includes more than 55 hospitals, 5 primary care networks and a nation-wide register in Finland.
COVIDRIVE Study Contributors network (as of 27th of July of 2023)
COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate”
  • Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
  • COVIREIVAC hospital network, France
  • Finnish Institute for Health and Welfare (THL, Finland)
  • Fisabio VAHNSI hospital network (Spain)
  • Hospital Universitario de Salamanca (Spain)
  • Hospital Universitario Germans Trias i Pujol (Spain)
  • Hospital Universitario La Paz (Spain)
  • Hospital Universitario Vall d’Hebron and Hospital Universitario Josep Trueta (Spain)
  • Grand Hôpital de Charleroi (Belgium)
  • University Hospital Antwerp (UZA, Belgium)
  • University Hospital Ghent (Belgium)
  • CHU Saint Pierre Hospital Brussels (Belgium)
  • GZIM GP network (Germany)
  • Forum Impfen GP network (Germany)
  • Uniklinikum Freiburg (Germany)
  • Universitätsklinikum Frankfurt (Germany)
  • Universitätsklinikum Ulm (Germany)
  • Universitätsklinikum Köln – DZIF (Germany)
  • Universitätsklinikum Hamburg-Eppendorf (Germany)
  • Iceland Directorate of Health (Iceland)
  • Imperial College London Health Partners (United Kingdom)
  • North West E-health (United Kingdom)
  • BREATHE consortium (United Kingdom)
  • Klinik Favoriten Hospital (Austria)
  • National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
  • National Institute of Public Health (Poland)
  • Hospital Fran Mihaljevic Zagreb (Croatia)
  • Aarhus University Hospital (Denmark)
  • Odense University Hospital (Denmark)